NCT00193297View on ClinicalTrials.gov

Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2006

Conditions
Ovary Cancer
Interventions
DRUG

Topotecan

DRUG

Paclitaxel

DRUG

Carboplatin

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER

NCT00193297 - Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma | Biotech Hunter | Biotech Hunter